Welcome to our dedicated page for Amrize SEC filings (Ticker: AMRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Amrize Ltd filings document a Swiss-incorporated North American building-solutions company with ordinary shares listed on the New York Stock Exchange and SIX Swiss Exchange. The company’s SEC reports include Form 8-K disclosures for quarterly and annual financial results, Regulation FD investor materials, dividend-related events, auditor changes, and board or executive appointments.
Proxy and annual meeting filings cover shareholder voting, board elections, compensation matters, distributions from legal reserves from capital contributions, and governance procedures under the company’s Swiss corporate structure. The filing record also documents Amrize’s completed spin-off from Holcim and related public-company reporting matters.
Amrize Ltd director Nicholas C. Gangestad reported routine equity compensation activity. He received a grant of 2,976 Ordinary Shares as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the company’s next regular annual shareholder meeting.
On the same date, 740 Ordinary Shares were disposed of as a tax-withholding transaction at a reference price of $57.12 per share, covering tax obligations tied to the vesting. Following these transactions, Gangestad directly owns 7,194 Ordinary Shares.
Amrize Ltd director Gibson Dwight Audley Konrad reported routine equity compensation activity. He acquired 2,976 Ordinary Shares at no cost as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan.
In connection with the vesting, 740 shares were disposed of to cover tax obligations at a price of $57.12 per share, a tax-withholding mechanism rather than an open-market sale. Following these transactions, he holds 5,194 Ordinary Shares directly.
Amrize Ltd director Wilbur Maria Cristina Alapag received a share-based compensation award. On April 21, 2026, Alapag acquired 2,976 Ordinary Shares at $0.00 per share as part of a restricted stock unit (RSU) award under the Amrize Ltd 2025 Omnibus Incentive Plan.
The filing also reports a related tax-withholding disposition of 190 Ordinary Shares at $57.12 per share, used to cover tax obligations on the vesting. Following these transactions, Alapag directly holds 5,934 Ordinary Shares.
Amrize Ltd director Sanche Jacques Wolf received an equity award of 2,976 Ordinary Shares as a restricted stock unit grant. The award was made at a price of $0.0000 per share under the Amrize Ltd 2025 Omnibus Incentive Plan and is described as a grant, award, or other acquisition.
The restricted stock units vest on the earlier of the one-year anniversary of the grant date and the date of Amrize Ltd's next regular annual meeting of shareholders. Following this grant, Wolf holds 5,616 Ordinary Shares directly and an additional 40 Ordinary Shares indirectly through a child.
Amrize Ltd director Robert S. Rivkin reported a share-based compensation event involving company ordinary shares. He received a grant of 2,976 shares at no cash cost as part of a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan.
In connection with the vesting of these restricted stock units, 740 shares were disposed of at a price of $57.12 per share to cover tax obligations, based on the closing price on the trading date of vesting. Following these transactions, his directly held ordinary shares were reported at 2,218.
Amrize Ltd director Roth Pellanda Katja Nicole reported compensation-related share activity. She acquired 2,976 Ordinary Shares at no cost as part of a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan. In a separate transaction, 190 Ordinary Shares were disposed of to cover tax obligations at a price of $57.12 per share.
The filing shows 5,744 Ordinary Shares held directly after the award transaction and 2,768 Ordinary Shares held directly after the tax-withholding disposition. The award vests on the earlier of the one-year anniversary of the grant date and the date of Amrize Ltd's next regular annual meeting of shareholders.
Amrize Ltd director Oleas Jurg Amadeo received a stock award and had shares withheld for taxes. On the reported date, he acquired 2,976 Ordinary Shares at no cost through a grant of restricted stock units under the Amrize Ltd 2025 Omnibus Incentive Plan. In a related tax-withholding disposition, 157 Ordinary Shares were delivered at a price of $57.12 per share to cover tax obligations on the vesting. After these transactions, he directly owns 23,892 Ordinary Shares.
NEWMAN DONALD P reported acquisition or exercise transactions in this Form 4 filing.
Amrize Ltd director Donald P. Newman received a restricted stock unit award of 2,976 Ordinary Shares. The grant was made at a price of $0.00 per share as equity compensation, increasing his direct holdings to 2,976 shares.
The award was granted under the Amrize Ltd 2025 Omnibus Incentive Plan and will vest on the earlier of the one-year anniversary of the grant date and the date of the company’s next regular annual meeting of shareholders. This is a compensation-related equity grant rather than an open-market share purchase.
Amrize Ltd director Michael E. McKelvy reported equity compensation activity involving the company’s ordinary shares. He received 2,976 shares as a grant or award at a stated price of $0.00 per share, tied to a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan.
In a related tax-withholding disposition, 740 shares were delivered at $57.12 per share to cover tax obligations upon vesting. Following the tax-withholding transaction, the filing shows McKelvy directly holding 2,218 ordinary shares. The restricted stock units vest on the earlier of one year from grant or the issuer’s next regular annual meeting of shareholders.
Amrize Ltd director Ladhani Holli C. reported equity compensation activity involving Ordinary Shares. The filing shows a grant of 2,976 shares at no cost as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan, which vests on the earlier of the one-year anniversary of the grant date or the issuer's next regular annual meeting of shareholders.
In a related tax-withholding disposition, 740 shares were delivered at a reference price of $57.12 per share, described as the closing price on the vesting date. One line in the filing shows 5,194 shares owned directly following the grant, while another shows 2,218 shares directly owned following the tax-withholding transaction, indicating routine compensation and tax-settlement activity rather than an open-market trade.